The next generation Covid-19 vaccines seeking a slice of the market
The next generation Covid-19 vaccines seeking a slice of the market A new group of vaccine makers is hoping to challenge the Covid-19 shots that are already household names, sharpening competition in what is set to be the first ever jab market to encompass the entire global population. BioNTech/Pfizer and Moderna, the pandemic’s mRNA-based vaccine frontrunners, have already booked billions of dollars in revenue, which they are using to boost production, sign new contracts and entrench their positions. Likewise, Oxford/AstraZeneca and Johnson & Johnson have been rolling out their cheaper and...